Copyright
©2014 Baishideng Publishing Group Inc.
World J Clin Oncol. Aug 10, 2014; 5(3): 197-223
Published online Aug 10, 2014. doi: 10.5306/wjco.v5.i3.197
Published online Aug 10, 2014. doi: 10.5306/wjco.v5.i3.197
Table 5 Onconeural antibodies
Well-characterized onconeural antibodies |
Anti-Hu (ANNA1) |
Anti-Yo (PCA1) |
Anti-CV2 (CRMP5) |
Anti-Ri (ANNA2) |
Anti-Ma2 (Ta) |
Anti-amphiphysin |
Partially characterized onconeural antibodies |
Anti-Tr (PCA-Tr) |
ANNA3 |
PCA2 |
Anti-Zic4 |
Anti-mGluR1 |
Other antibodies |
Anti-acetylcholine receptor |
Anti-nicotinic AchR |
Anti-voltage-gated calcium channel |
Anti-voltage-gated potassium channel |
Anti-NR1/NR2 of N-methyl-D-aspartate |
Anti-glutamic acid decarboxylase |
- Citation: Kanaji N, Watanabe N, Kita N, Bandoh S, Tadokoro A, Ishii T, Dobashi H, Matsunaga T. Paraneoplastic syndromes associated with lung cancer. World J Clin Oncol 2014; 5(3): 197-223
- URL: https://www.wjgnet.com/2218-4333/full/v5/i3/197.htm
- DOI: https://dx.doi.org/10.5306/wjco.v5.i3.197